Contents hide 1 Melanoma 1.1 BRAF V600E mutation-positive unresectable or metastatic melanoma 1.2 BRAF V600E or V600K mutation-positive unresectable or metastatic melanoma 1.3 Adjuvant treatment of BRAF V600E or V600K mutation-positive melanoma 2 Non-Small Cell Lung Cancer 3 Thyroid Cancer, Locally Advanced or Metastatic 4 BRAF V600E Mutation-Positive Solid Tumors Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the gene BRAF.Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth. Melanoma BRAF V600E mutation-positive unresectable or metastatic melanoma Indicated as a single agent 150 mg PO BID … Continue reading DABRADX (Dabrafenib)